Evidence map›Paper›PMID 33225937›Full record

ArticleReproductive biology and endocrinology : RB&E2020

Establishment of an immortalized stromal cell line derived from human Endometriotic lesion.

Zhi-Xiong Huang, Rong-Feng Wu, Xiao-Mei Mao, Shao-Min Huang, Tian-Tian Liu, Qiong-Hua Chen, Qing-Xi Chen

Open access · goldAbstract read
In one paragraph

Article in Reproductive biology and endocrinology : RB&E, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.6field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Zhi-Xiong HuangSchool of Life Sciences, Xiamen University, Xiamen, 361102, China.
Rong-Feng WuReproductive Medical Center, The First Affiliated Hospital of Xiamen University, Xiamen, China.
Xiao-Mei MaoSchool of Life Sciences, Xiamen University, Xiamen, 361102, China.
Shao-Min HuangReproductive Medical Center, The First Affiliated Hospital of Xiamen University, Xiamen, China.
Tian-Tian LiuSchool of Life Sciences, Xiamen University, Xiamen, 361102, China.
Qiong-Hua ChenThe Key Laboratory of Research and Diagnosis of Gynecological Diseases of Xiamen City and Department of Obstetrics and Gynecology, the First Affiliated Hospital of Xiamen University, Xiamen, 361003, China. cqhua616@126.com.ORCID http://orcid.org/0000-0003-4637-9813
Qing-Xi ChenSchool of Life Sciences, Xiamen University, Xiamen, 361102, China. chenqx@xmu.edu.cn.
Xiamen University · CNFirst Affiliated Hospital of Xiamen University · CN

Funding

National Science Foundation of China 81701419National Science Foundation of China 81871145Science and Technology Planning Project of Xiamen City 2018S2326
6 · The paper itself

Abstract

backgroundEndometriosis is a benign gynecological disease with obviously feature of estrogen-dependence and inflammatory response. The applications of primary endometriotic stromal cells in research of endometriosis are restricted for short life span, dedifferentiation of hormone and cytokine responsiveness. The objective of this study was to establish and characterize immortalized human endometriotic stromal cells (ihESCs).

methodsThe endometriotic samples were from a patient with ovarian endometriosis and the primary endometriotic stromal cells were isolated from the endometriotic tissues. The primary cells were infected by lentivirus to establish telomerase reverse transcriptase (hTERT)-induced immortalized cells. Quantification of mRNA and proteins was examined by quantitative real-time polymerase chain reaction (qRT-PCR) and Western Blot. CCK-8 assay and EdU labeling assay were assigned to assess the growth of ihESCs. Karyotype assay was performed to detect the chromosomes of ihESCs. Colony formation assay and nude mouse tumorigenicity assay were used to evaluate colony-formation and tumorigenesis abilities.

resultsihESCs continuously overexpressed hTERT via infection of lentivirus and significant extended the life span reaching 31 passages. The morphology, proliferation and karyotype of ihESCs remained unchanged. The expression of epithelial-mesenchymal transition (EMT) markers, estrogen-metabolizing proteins and estrogen/progesterone receptors (ERs and PRs) were unaltered. Furthermore, the treatment of estrogen increased the proliferation and EMT of ihESCs. Lipopolysaccharides (LPS) and IL-1β remarkably induced inflammatory response. The clonogenesis ability of ihESCs was consistent with primary cells, which were much lower than Ishikawa cells. In addition, nude mouse tumorigenicity assay demonstrated that ihESCs were unable to trigger tumor formation.

conclusionThis study established and characterized an immortalized endometriotic stromal cell line that exhibited longer life span and kept the cellular morphology and physiological function as the primary cells. The immortalized cells remained normal feedback to estrogen and inflammatory response. Moreover, the immortalized cells were not available with tumorigenic ability. Therefore, ihESCs would be serviceable as in vitro cell tool to investigate the pathogenesis of endometriosis.

Indexed as

Gene ExpressionAnimalsCell Line, TransformedCell Line, TumorCell ProliferationCells, CulturedCell SurvivalEndometriosisEndometriumEpithelial-Mesenchymal TransitionFemaleHumansMice, Inbred BALB CMice, NudeStromal CellsTransplantation, HeterologousEndometriotic stromal cellsEstrogenImmortalizedInflammationTumorigenicity

Identifiers

PMID33225937
PMCPMC7682002
OpenAlexW3107365226

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.